相关实验视频

Updated: Jun 17, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K

基于FDA的不良事件报告系统的CDK4/6抑制剂相关不良事件的比较分析:一个病例控制药监测研究

Wanlong Lin1, Yanbin Zeng1, Lizhu Weng1

  • 1Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.

BMC pharmacology & toxicology
|August 9, 2024
PubMed
概括

循环素依赖性激酶4/6 (CDK4/6) 抑制剂在乳腺癌治疗中具有不同的安全性. 帕尔博西克利布可能会导致血液毒性,里博西克利布可能会导致肝毒性和QT延长,而阿贝马西克利布可能会导致胃肠道影响和间歇性肺病.

关键词:
阿贝马西克利布 (Abemaciclib) 是一个女性.这是一种CDK4/6抑制剂.公平的人是公平的.血液学毒性 血液学毒性肝毒性 肝毒性 肝毒性间歇性肺病 间歇性肺病毒性 毒性 毒性在Palbocicliblib中使用.里博西克利布 (Ribociclib) 是一种可靠的药物.副作用 副作用 副作用 副作用

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.5K
Comprehensive Analysis of Drug Response using the FLICK Assay09:38

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

49

相关概念视频

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
106